Commentary
Guidance for Practicing Primary Care
How the new depression screening guidelines in adults do little to address our mental health care crisis
It is good that screening is now recommended, but we need to do more to tear down the stigma attached to mental illness.
Commentary
The biggest mistake we could make with obesity drugs
Too often lost in news stories about the success of obesity drugs like tirzepatide and semaglutide is that research study participants also...
Commentary
10 ways docs sabotage their patients’ weight loss journeys
Stopping medications for obesity when weight is lost. Do you also stop blood pressure medications when they normalize a patient’s blood pressure...
Commentary
Lessons from the longest study on happiness
To some surprise, researchers determined that good relationships were the most significant predictor of health and happiness during aging.
Commentary
Does rapid weight loss from GLP-1s decrease muscle mass?
Providers prescribing medications like GLP-1 agonists to treat obesity must also counsel patients about incorporating aerobic exercise and...
Commentary
Has the time come to bury BMI in favor of other screening measures?
While BMI is a quick and inexpensive means to assess obesity, by itself it lacks the necessary components for an accurate diagnosis.
Conference Coverage
Debate: Initial combination therapy for type 2 diabetes?
Ralph A. DeFronzo, MD, argued for combination therapy at the time of diagnosis, and David M. Nathan, MD, countered that sequential therapy is a...
Commentary
Conflicting blood pressure targets: Déjà vu all over again
Arguing about 140/90 mm Hg or 130/80 mm Hg is less important than acknowledging that we should be aggressive in screening for and treating...
Commentary
The surprising occupations with higher-than-expected ovarian cancer rates
This is how these types of studies work; they tend to raise more questions than they answer.
Commentary
‘Body size is not a choice’ and deserves legal protections
Weight-based discrimination in the United States has increased by an estimated 66% over the past decade, putting it on par with the prevalence of...
Feature
Parsing the split-decision victory for biologics in COPD
It’s tough to keep up with the proliferation of monoclonal antibodies.